Electrolyte Blood Press.  2014 Jun;12(1):7-18. 10.5049/EBP.2014.12.1.7.

Dietary Salt Intake and Hypertension

• Ha SK

• KMID: 1708552
• DOI: http://doi.org/10.5049/EBP.2014.12.1.7

Abstract

Over the past century, salt has been the subject of intense scientific research related to blood pressure elevation and cardiovascular mortalities. Moderate reduction of dietary salt intake is generally an effective measure to reduce blood pressure. However, recently some in the academic society and lay media dispute the benefits of salt restriction, pointing to inconsistent outcomes noted in some observational studies. A reduction in dietary salt from the current intake of 9-12 g/day to the recommended level of less than 5-6 g/day will have major beneficial effects on cardiovascular health along with major healthcare cost savings around the world. The World Health Organization (WHO) strongly recommended to reduce dietary salt intake as one of the top priority actions to tackle the global non-communicable disease crisis and has urged member nations to take action to reduce population wide dietary salt intake to decrease the number of deaths from hypertension, cardiovascular disease and stroke. However, some scientists still advocate the possibility of increased risk of CVD morbidity and mortality at extremes of low salt intake. Future research may inform the optimal sodium reduction strategies and intake targets for general populations. Until then, we have to continue to build consensus around the greatest benefits of salt reduction for CVD prevention, and dietary salt intake reduction strategies must remain at the top of the public health agenda.

Keyword

Dietary salt; Restriction; Target; Hypertension

MeSH Terms

Blood Pressure
Cardiovascular Diseases
Consensus
Dissent and Disputes
Health Care Costs
Hypertension*
Income
Mortality
Public Health
Sodium
Stroke
World Health Organization
Sodium

Reference

1. World Health Organization. Reducing salt intake in populations. Report of WHO Forum and Technical Meeting. Paris: 2006.

2. Alderman MH. Reducing dietary sodium: the case for caution. JAMA. 2010; 303:448–449. PMID: 20124541.

3. Kolata G. No benefit seen in sharp limits of salt in diet. The New York Times. 2013.

4. MacGregor GA, de Wardener HE. Salt, Diet and Health: Neptune's Poisoned Chalice; The origin of High Blood Pressure. Cambridge: Cambridge University Press;1998. p. 233.

5. Kurlansky M. Salt: A World History. New York: Penguin Books;2002. p. 18–19.

6. Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001; 88:1338–1346. PMID: 11728372.

7. A brief history of salt. Time Magazine;1982.

8. Ritz E. The history of salt-aspects of interest to the nephrologist. Nephrol Dial Transplant. 1996; 11:969–975. PMID: 8671953.

9. He FJ, Macgregor GA. Reducing population salt intake worldwide: From evidence to implementation. Prog Cardiovasc Dis. 2010; 52:363–382. PMID: 20226955.

10. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ. 1988; 297:319–328. PMID: 3416162.

11. Buss D, Robertson J. Manual of Nutrition. London: Her Majesty's Stationery Office;1981. p. 37–38.

12. Wood FO. "Salt (NaCl)". Encyclopædia Britannica. online Academic Edition. Encyclopædia Britannica Inc.;2012.

13. Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev. 2005; 85:679–715. PMID: 15788708.

14. He FJ, MacGregor GA. Salt, blood pressure andcardiovascular disease. Curr Opin Cardiol. 2007; 22:298–305. PMID: 17556881.

15. Delahaye F. Should we eat less salt? Arch Cardiovasc Dis. 2013; 106:324–332. PMID: 23769406.

16. Ambard L, Beaujard E. Causes de l' hypertension arterielle. Arch Gen Med. 1904; 1:520–533.

17. Kempner W. Treatment of hypertensive vascular disease-with the rice diet. Am J Med. 1948; 4:545–577. PMID: 18909456.

18. Ball CO, Meneely GR. Observations on dietary sodium chloride. J Am Diet Assoc. 1957; 33:366–370. PMID: 13415846.

19. Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moisson P, Pingard AM, Shade R, Carey D, Ardaillou R, Paillard F, Chapman J, Thillet J, Michel JB. The effect of increased salt intake on blood pressure of chimpanzees. Nat Med. 1995; 1:1009–1016. PMID: 7489355.

20. Watkin DM, Froeb HF, Hatch FT, Gutman AB. Effects of diet in essential hypertension: II. Results with unmodified Kempner rice diet in fifty hospitalized patients. Am J Med. 1950; 9:441–493. PMID: 14771097.

21. Fodor JG, Abbott EC, Rusted IE. An epidemiologic study of hypertension in Newfoundland. Can Med Assoc J. 1973; 108:1365–1368. PMID: 4704904.

22. Page LB, Damon A, Moellering RC Jr. Antecedents of cardiovascular disease in six Solomon Islands societies. Circulation. 1974; 49:1132–1146. PMID: 4831656.

23. Poulter NR, Khaw KT, Hopwood BE, Mugambi M, Peart WS, Rose G, Sever PS. The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. BMJ. 1990; 300:967–972. PMID: 2344502.

24. Poulter NR, Khaw KT, Mugambi M, Peart WS, Sever PS. Migration-induced changes in blood pressure: a controlled longitudinal study. Clin Exp Pharmacol Physiol. 1985; 12:211–216. PMID: 4028511.

25. He J, Klag MJ, Whelton PK, Chen JY, Mo JP, Qian MC, Mo PS, He GQ. Migration, blood pressure pattern, and hypertension: the Yi Migrant Study. Am J Epidemiol. 1991; 134:1085–1101. PMID: 1746519.

26. MacGregor GA, Markandu ND, Best FE, Elder DM, Cam JM, Sagnella GA, Squires M. Double-blind randomised crossovertrial of moderate sodium restriction in essential hypertension. Lancet. 1982; 1:351–355. PMID: 6120346.

27. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24h urinary sodium and potassium excretion. BMJ. 1988; 297:319–328. PMID: 3416162.

28. Mancilha-Carvalho JJ, de Oliveira R, Esposito RJ. Blood pressure and electrolyte excretion in the Yanomamo Indians, an isolated population. J Hum Hypertens. 1989; 3(5):309–314. PMID: 2810327.

29. Elliott P, Stamler J, Nichols R, et al. for the INTERSALT Cooperative Research Group. Intersal revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. BMJ. 1996; 312:1249–1253. PMID: 8634612.

30. Forte JG, Miguel JM, Miguel MJ, de Padua F, Rose G. Salt and blood pressure: a community trial. J Hum Hypertens. 1989; 3:179–184. PMID: 2671369.

31. Tian HG, Guo ZY, Hu G, Yu SJ, Sun W, Pietinen P, Nissinen A. Changes in sodium intake and blood pressure in a community-based intervention project in China. J Hum Hypertens. 1995; 9:959–968. PMID: 8746640.

32. Staessen J, Bulpitt CJ, Fagard R, Joossens JV, Lijnen P, Amery A. Salt intake and blood pressure in the general population: a controlled intervention trial in two towns. J Hypertens. 1988; 6:965–973. PMID: 3065411.

33. Cutler JA, Follmann D, Allender PS. Randomized trials of sodium reduction: an overview. Am J Clin Nutr. 1997; 65(2 Suppl):643S–651S. PMID: 9022560.

34. Midgley JP, Matthew AG, Greenwood CM, Logan AG. Effect of reduced dietary sodium on blood pressure: A meta-analysis of randomized controlled trials. JAMA. 1996; 275:1590–1597. PMID: 8622251.

35. Graudal NA, Galloe AM, Garred P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis. JAMA. 1998; 279:1383–1391. PMID: 9582047.

36. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I. JAMA. 1992; 267:1213–1220. PMID: 1586398.

37. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: the Trials of Hypertension Prevention, phase II. Arch Intern Med. 1997; 157:657–667. PMID: 9080920.

38. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the Trials of Hypertension Prevention (TOHP). BMJ. 2007; 334:885–888. PMID: 17449506.

39. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S, Cutler JA. TONE Collaborative Research Group. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA. 1998; 279:839–846. PMID: 9515998.

40. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER III, Simons-Morton DG, Karanja N, Lin PH. DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 2001; 344:3–10. PMID: 11136953.

41. He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens. 2002; 16(11):761–770. PMID: 12444537.

42. He J, Ogden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA. 1999; 282:2027–2034. PMID: 10591385.

43. Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P, Nissinen A. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet. 2001; 357:848–851. PMID: 11265954.

44. O'Donnell MJ, Yusuf S, Mente A, Gao P, Mann JF, Teo K, McQueen M, Sleight P, Sharma AM, Dans A, Probstfield J, Schmieder RE. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA. 2011; 306:2229–2238. PMID: 22110105.

45. Strazzullo P, D'Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: metaanalysis of prospective studies. BMJ. 2009; 339:b4567. PMID: 19934192.

46. Alderman MH, Madhavan S, Cohen H, Sealey JE, Laragh JH. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension. 1995; 25:1144–1152. PMID: 7768554.

47. Cohen HW, Hailpern SM, Fang J, Alderman MH. Sodium intake and mortality in the NHANES II follow-up study. Am J Med. 2006; 119:275.e7–275.e14. PMID: 16490476.

48. Alderman MH. Presidential Address: 21^st Scientific Meeting of the International Society of Hypertension: dietary sodium and cardiovascular disease: the 'J'-shaped relation. J Hypertens. 2007; 25:903–907. PMID: 17414648.

49. Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerová J, Richart T, Jin Y, Olszanecka A, Malyutina S, Casiglia E, Filipovský J, Kawecka-Jaszcz K, Nikitin Y, Staessen JA. European Project on Genes in Hypertension (EPOGH) Investigators: Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA. 2011; 305:1777–1785. PMID: 21540421.

50. He FJ, Appel LJ, Cappuccio FP, de Wardener HE, MacGregor GA. Does reducing salt intake increase cardiovascular mortality? Kidney Int. 2011; 80:696–698. PMID: 21814179.

51. Taylor RS, Ashton KE, Moxham T, Hooper L, Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane Review). Am J Hypertens. 2011; 24:843–853. PMID: 21731062.

52. He F, MacGregor GA. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet. 2011; 378:380–382. PMID: 21803192.